Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00405093 · ClinicalTrials.gov registry record
Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta.
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 1,250
- Enrollment target
NCT00405093: Completed study, sponsored by Weill Medical College of Cornell University.
NCT00405093 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1,250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00405093 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 1,250 participants
- Enrollment target
Study Summary
Primary Objective: The aim of this study is to assess the effects of Aprotinin (an antifibrinolytic drug used to reduce bleeding during cardiac surgery) on renal function in patients undergoing surgery with use of hypothermic bypass and circulatory arrest for repair of the thoracic aorta. Secondary Objective: To compare the effects of Aprotinin and Amicar on major vascular outcomes following thoracic aorta surgery with use of hypothermic bypass and circulatory arrest.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2006-07 |
| Est. Completion | 2013-05 |
What the finished NCT00405093 record still lists
NCT00405093 is an observational study that tracks outcomes without assigning an intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00405093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00405093 about?
NCT00405093 is a clinical study titled "Aprotinin Use and Renal Outcome in Hypothermic Bypass and Circulatory Arrest for Surgical Repair of Thoracic Aorta.". Primary Objective: The aim of this study is to assess the effects of Aprotinin (an antifibrinolytic drug used to reduce bleeding during cardiac surgery) on renal function in patients undergoing surgery with use of hypothermic bypass and circulatory arrest for repair of the thoracic aorta. Secondary...
What is the current status of trial NCT00405093?
This trial is currently completed. The enrollment target is 1,250 participants. The study started on 2006-07. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00405093?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia